Notch3 pathway alterations in ovarian cancer

Related Experiment Video

Updated: May 1, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.3K

Wei Hu1, Tao Liu1, Cristina Ivan2

  • 1Authors' Affiliations: Departments of Gynecologic Oncology and Reproductive Medicine, Systems Biology, Pathology, Experimental Therapeutics, Bioinformatics and Computational Biology, Cancer Biology, Thoracic/Head and Neck Medical Oncology, and The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Cancer Research
|April 19, 2014
PubMed

Insights

Notch pathway alterations, especially Notch3, are common in ovarian cancer and linked to poor survival. Targeting Notch3 shows promise for inhibiting cancer growth and improving patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • The Notch pathway is implicated in high-grade serous ovarian cancer (HGS-OvCa) growth.
  • Clinical and biological mechanisms of the Notch pathway in cancer are not fully understood.

Purpose of the Study:

  • To investigate the role of Notch pathway alterations in ovarian cancer.
  • To identify mechanisms of Notch3 signaling and potential therapeutic targets.

Main Methods:

  • Analysis of Notch pathway alterations in patient data.
  • Investigating the effect of targeting Notch3 on ovarian cancer growth and apoptosis.
  • Studying the role of dynamin-mediated endocytosis in Notch3 signaling.
  • Assessing cleaved Notch3 expression as a biomarker for therapy response.

Main Results:

  • Notch pathway alterations are prevalent in ovarian cancer and correlate with poor clinical outcomes.
  • Notch3 alterations (amplification, upregulation) are significantly associated with reduced patient survival.
  • Targeting Notch3 effectively inhibited ovarian cancer growth and induced apoptosis.
  • Dynamin-mediated endocytosis is crucial for Jagged-1-mediated Notch3 signaling activation.
  • Cleaved Notch3 expression is a key determinant of response to Notch-targeted therapies.

Conclusions:

  • Notch pathway alterations, particularly Notch3, represent significant biomarkers for poor prognosis in ovarian cancer.
  • Notch3 signaling involves dynamin-mediated endocytosis and Jagged-1 activation.
  • Targeting Notch3 offers a promising, biomarker-driven therapeutic strategy for ovarian cancer.

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

13.8K

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.6K
Notch Signaling Pathway03:14

Notch Signaling Pathway

4.9K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
6.4K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K